General
Australian AstraZeneca manufacturer CSL still committed to make 50 million vaccine doses
The Australian manufacturer of the AstraZeneca COVID-19 vaccine says it still plans to fill a federal government order of 50 million doses, despite health authorities recommending a different vaccine be preferred for those under 50 years of age.
Key points:
- CSL says it remains “committed to meeting its contracted arrangements” with the Australian government and AstraZeneca
- An expert panel has advised that the Pfizer vaccine is preferred for people under 50
- The federal government expects CSL will soon start producing one million AstraZeneca doses per week
On Thursday night, the panel of experts that advises the federal government on immunisation issues recommended that Pfizer be the preferred COVID-19 vaccine for adults under 50 due to the…
-
Noosa News19 hours agoIncrease in extreme weather events poses ‘substantial risk’ to blood supplies, researchers warn
-
General23 hours agoGerman palliative care doctor with alleged ‘lust for murder’ accused of killing 15 patients
-
Noosa News9 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate
-
Noosa News20 hours ago‘Low morale, decreasing trust in leadership’: Top cop’s stark warning